Pharmacology of cannabinoids in the treatment of epilepsy.

Author(s): Gaston TE, Friedman D

Department of Neurology, Division of Epilepsy, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: [email protected]

Subject: Epilepsy View the study


The use of cannabis products in the treatment of epilepsy has long been of interest to researchers and clinicians alike; however, until recently very little published data were available to support its use. This article summarizes the available scientific data of pharmacology from human and animal studies on the major cannabinoids which have been of interest in the treatment of epilepsy, including ∆9-tetrahydrocannabinol (∆9-THC), cannabidiol (CBD), ∆9-tetrahydrocannabivarin (∆9-THCV), cannabidivarin (CBDV), and ∆9-tetrahydrocannabinolic acid (Δ9-THCA).

Source: Epilepsy & Behavior (Price: $36)
Share Tweet

More medical studies related to Epilepsy:

View all medical studies >>

Subscribe for daily cannabis news, announcements, and business insights.

Buy Provimed online in USA